(Q39647685)

English

Combined inhibitory effects of celecoxib and fluvastatin on the growth of human hepatocellular carcinoma xenografts in nude mice

scientific article published on July 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Combined inhibitory effects of celecoxib and fluvastatin on the growth of human hepatocellular carcinoma xenografts in nude mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

J Gao

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

W-D Jia

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

J-S Li

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

W Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

G-L Xu

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

J-L Ma

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Y-S Ge

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

J-H Yu

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

W-H Ren

9

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

W-B Liu

10

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

C-H Zhang

11

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

1 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Journal of International Medical Research

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1413-1427

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Estimating the world cancer burden: Globocan 2000.

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Many actions of cyclooxygenase-2 in cellular dynamics and in cancer

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E2 production

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Selective inhibition of cyclooxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Regulation of the mevalonate pathway

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

3-Hydroxy-3-methylglutaryl coenzyme A reductase activity and low-density lipoprotein receptor expression in diffuse-type and intestinal-type human gastric cancer

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors. Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Atorvastatin and Celecoxib Inhibit Prostate PC-3 Tumors in Immunodeficient Mice

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Breast cancer growth prevention by statins

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Determination of subcutaneous tumor size in athymic (nude) mice

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Statin induces apoptosis and cell growth arrest in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Double-edged role of statins in angiogenesis signaling

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Statins and angiogenesis: is it about connections?

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

AKT/PKB signaling: navigating downstream

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence.

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

3-phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Statins induce mammalian target of rapamycin (mTOR)-mediated inhibition of Akt signaling and sensitize p53-deficient cells to cytostatic drugs

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Statins inhibit Akt/PKB signaling via P2X7 receptor in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atorvastatin.

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship?

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing P53.

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Validating survivin as a cancer therapeutic target

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Survivin as a therapeutic target for radiation sensitization in lung cancer.

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Celecoxib induces apoptosis by inhibiting the expression of survivin in HeLa cells

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Statins activate a mitochondria-operated pathway of apoptosis in breast tumor cells by a mechanism regulated by ErbB2 and dependent on the prenylation of proteins

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800423

21 January 2018

Identifiers

10.1177/147323001003800423

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39647685&oldid=1849860161"